JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kataoka, K.
Right arrow Articles by Sasayama, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kataoka, K.
Right arrow Articles by Sasayama, S.
Journal of Nuclear Medicine Vol. 42 No. 1 124-129
© 2001 by Society of Nuclear Medicine


BASIC SCIENCE INVESTIGATIONS

Myocardial Lipid Metabolism in Compensated and Advanced Stages of Heart Failure: Evaluation by Canine Pacing Model with BMIPP

Kazuaki Kataoka, Ryuji Nohara, Ryohei Hosokawa, Taku Hirai, Kazumi Okuda, Chen Li-Guang, Yasuhisa Fujibayashi, Masatoshi Fujita, Junji Konishi and Shigetake Sasayama

Departments of Cardiovascular Medicine and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto; and Biomedical Imaging Research Center, Fukui Medical University, Fukui, Japan

The normal myocardium uses primarily fatty acid as its energy source, but, as heart failure develops, the myocardial fatty acid metabolism is limited. In this study, impairment of the lipid metabolism in heart failure was serially evaluated with 123I-({rho}-iodophenyl)-3-(R,S)-methylpentadecanoic acid (BMIPP), a radioiodinated fatty acid analog. Methods: Rapid ventricular pacing was introduced in 10 beagle dogs. Dogs were subjected to hemodynamic assessment and measurement of catecholamine before and after pacing. After 1 wk (group A; n = 4) and 4 wk (group B; n = 6) of pacing, BMIPP was injected directly into the left anterior descending artery; its extraction, retention, and washout rate in the early phase were calculated, and the metabolites in the myocardium were evaluated using high-performance liquid chromatography. These factors were compared with those of healthy control animals (group C; n = 6). Results: The left ventricular ejection fraction and cardiac output decreased significantly in groups A and B after pacing. The pulmonary capillary wedge pressure did not change in group A but increased significantly in group B. Plasma norepinephrine increased progressively as heart failure developed but did not reach statistical significance. The washout rate in the early phase increased, significantly in groups A and B compared with that of group C. Extraction and retention of BMIPP did not change in group A. In group B, extraction tended to decrease and retention decreased significantly compared with that of group C. The levels of full metabolite formed by complete oxidation of BMIPP decreased, and backdiffusion of BMIPP increased significantly in groups A and B compared with that of group C. Myocardial blood flow did not change among the three groups. Conclusion: Our study indicates that myocardial fatty acid oxidation begins to be inhibited and that washout of BMIPP increases in the compensated stage of left ventricular dysfunction but that myocardial extraction and retention of fatty acid are definitely impaired in the advanced stage of heart failure. Therefore, as assessed by BMIPP, the myocardial lipid metabolism is related to the pathophysiology of the development and worsening of heart failure.

Key Words: myocardial fatty acid metabolism • 123I-BMIPP • pacing-induced heart failure




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
G. D. Lopaschuk, J. R. Ussher, C. D. L. Folmes, J. S. Jaswal, and W. C. Stanley
Myocardial Fatty Acid Metabolism in Health and Disease
Physiol Rev, January 1, 2010; 90(1): 207 - 258.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. Kitagawa, K. Takeda, K. Saito, S. Okamoto, K. Makino, H. Maeda, and T. Ichihara
Differences in Fatty Acid Metabolic Disorder Between Ischemic Myocardium and Doxorubicin-Induced Myocardial Damage: Assessment Using BMIPP Dynamic SPECT with Analysis by the Rutland Method
J. Nucl. Med., October 1, 2002; 43(10): 1286 - 1294.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.